Health Condition 1: D259- Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention1: Erector Spinae Plane block: Group A (Control group): 40ml 0.25% Ropivacaine(20ml on each side) in Normal Saline (in 1:1 ratio)
Control Intervention1: ESPB with Ropivacaine: Group A (Con
Sponsors
Swami Rama Himalayan University
Eligibility
Inclusion criteria
Inclusion criteria: ? All Patients giving written informed consent Females undergoing elective Abdominal Hysterectomy surgeries. American Society Of Anaesthesiology(ASA) physical status Grade I, II Incision- Pfannenstiel
Exclusion criteria
Exclusion criteria: Patient’s refusal to participate in study Cognitive impairment or active psychiatric condition Infection at local site Bleeding disorders Contraindications to any of the drugs used in the study(allergy) Lactation Drug abuse Severe liver and kidney disease ASA=3 Midline incision Dyscholestrolemia Severe cardiovascular/Respiratory risk Coagulation disorders Allergy to local anaesthetic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total amount of opioid consumption in first 24 hoursTimepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time of first rescue analgesic request( time from PACU shifting to first requested rescue analgesic)Timepoint: 24 hours;Total amount of prescribed analgesic in PACUTimepoint: 24 hours;Any opioid related side effects like respiratory depression, pruritis within the first 24 hours.Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactHarish Koshyari
Himalayan Institute of medical Sciences
Outcome results
None listed